Ausbil Investment Management LTD Adma Biologics, Inc. Transaction History
Ausbil Investment Management LTD
- $166 Billion
- Q4 2024
A detailed history of Ausbil Investment Management LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Ausbil Investment Management LTD holds 8,126 shares of ADMA stock, worth $134,729. This represents 0.09% of its overall portfolio holdings.
Number of Shares
8,126Holding current value
$134,729% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
314Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$309 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$300 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$216 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$209 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$143 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.26B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...